We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRS
2826
DELISTED
Amyris Inc.
AMRS
| $141K | ﹤0.01% |
42,112
+14,546
| +53% | +$83.8K |
|
|
USX
2827
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $140K | ﹤0.01% |
24,914
+8,846
| +55% | +$74.3K |
|
|
PYX
2828
DELISTED
Pyxus International, Inc.
PYX
| $140K | ﹤0.01% |
+11,788
| New | +$247K |
|
|
OSG
2829
DELISTED
Overseas Shipholding Group Inc.
OSG
| $138K | ﹤0.01% |
83,094
+24,798
| +43% | +$62.9K |
|
|
MRNS
2830
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $138K | ﹤0.01% |
12,041
+3,954
| +49% | +$80K |
|
|
HIVE
2831
DELISTED
Aerohive Networks
HIVE
| $138K | ﹤0.01% |
42,443
+14,394
| +51% | +$54.2K |
|
|
WIN
2832
DELISTED
Windstream Holdings Inc
WIN
| $138K | ﹤0.01% |
66,174
+18,831
| +40% | +$70.1K |
|
|
VIVS
2833
VivoSim Labs
VIVS
$1.27M
| $137K | ﹤0.01% |
596
+206
| +53% | +$51.9K |
|
|
CVIA
2834
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $136K | ﹤0.01% |
39,632
+12,881
| +48% | +$77.6K |
|
2835
Global Water Resources
GWRS
$211M
| $135K | ﹤0.01% |
+13,321
| New | +$139K |
|
2836
Gyre Therapeutics
GYRE
$695M
| $134K | ﹤0.01% |
2,267
+683
| +43% | +$50.4K |
|
|
CURO
2837
DELISTED
CURO Group Holdings Corp.
CURO
| $134K | ﹤0.01% |
14,120
+5,423
| +62% | +$88.8K |
|
|
RYZ
2838
Ryerson Holding Corp
RYZ
$1.43B
| $133K | ﹤0.01% |
20,940
+6,860
| +49% | +$59.3K |
|
|
TEF
2839
DELISTED
Telefonica
TEF
| $133K | ﹤0.01% |
19,493
| – | – |
|
|
CLUB
2840
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $133K | ﹤0.01% |
20,799
+5,830
| +39% | +$44.1K |
|
2841
Evolus
EOLS
$407M
| $129K | ﹤0.01% |
+10,851
| New | +$155K |
|
2842
Gencor Industries
GENC
$212M
| $129K | ﹤0.01% |
+11,754
| New | +$134K |
|
|
INSY
2843
DELISTED
Insys Therapeutics, Inc.
INSY
| $129K | ﹤0.01% |
36,822
+11,657
| +46% | +$81K |
|
|
GFN
2844
DELISTED
General Finance Corporation
GFN
| $129K | ﹤0.01% |
+12,777
| New | +$166K |
|
2845
J. Jill
JILL
$287M
| $127K | ﹤0.01% |
5,672
+1,584
| +39% | +$36.3K |
|
2846
Nomura Holdings
NMR
$29B
| $125K | ﹤0.01% |
33,656
+118
| +0.4% | +$529 |
|
|
IOTS
2847
DELISTED
Adesto Technologies Corp
IOTS
| $125K | ﹤0.01% |
28,486
+10,990
| +63% | +$52.5K |
|
2848
Safe Bulkers
SB
$778M
| $124K | ﹤0.01% |
69,840
+20,183
| +41% | +$45.7K |
|
2849
FS KKR Capital
FSK
$3.09B
| $123K | ﹤0.01% |
5,916
+3,170
| +115% | +$78.9K |
|
2850
Seres Therapeutics
MCRB
$48.4M
| $123K | ﹤0.01% |
1,357
+445
| +49% | +$62.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.